Study objective Temporary lower limb immobilization may be a risk for venous
thromboembolism. The purpose of this study was to examine the 90-day incidence of …

Pulmonary embolism (PE) is the third leading cause of cardiovascular mortality. The
management of PE is currently evolving given the development of new technologies and …

There is clinical practice variation in the area of prevention and management of venous
thromboembolism (VTE) in pregnancy. There are limited data and differing …

Essentials• The minimal clinically important difference (MCID) for PEmbQoL has not yet
been determined.• We estimated the MCID for PEmbQoL and its subscales via anchor‐and …

Pulmonary embolism (PE) is a potential life-threatening condition and risk-adapted
diagnostic and therapeutic management conveys a favorable outcome. For patients at high …

Pulmonary embolism (PE) is a major cause of morbidity and mortality worldwide. In the
United States alone, it is estimated that up to 100,000 PE-related deaths occur each year …

Accurate estimation of risk with both imaging and biochemical parameters in intermediate
risk pulmonary embolism (PE) remains challenging. The aim of the study was to evaluate …

Chronic thromboembolic pulmonary hypertension (CTEPH) is a progressive pulmonary
vascular disease characterized by chronic obstruction of major pulmonary arteries with flow …

Introduction: Acute pulmonary embolism (PE) is a common cardiovascular condition
resulting in significant morbidity and mortality. Consensus recommendations suggest risk …

Catheter‐directed therapies for the treatment of high risk (massive) and intermediate risk (submassive)
acute pulmonary embolism - Harvey, JJ - 2022 | Cochrane Library Skip to Content Cookies …